Market Tracker

08/28 6:45pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

95.04
Delayed Data
As of Aug 28
 +0.79 / +0.84%
Today’s Change
41.99
Today|||52-Week Range
112.40
+78.61%
Year-to-Date

Today’s Trading

Previous close94.25
Today’s open93.51
Day’s range93.10 - 95.64
Volume326,134
Average volume (3 months)428,439
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+131.80%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+31.78%
P/E ratio61.2
Price/Sales17.67
Price/Book70.69

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-0.09-0.15%
USNAUSANA Health Science...-3.42-2.30%
LCILannett Company Inc-0.17-0.34%
FOLDAmicus Therapeutics ...+0.02+0.13%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.42
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts